Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The... by Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Yanina Balabanova, Gunnar Brobert, Samuel Fatoba, Ana Ruigomez, Oscar Fernandez

Get full text

Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK by Mar Martín-Pérez, Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Yanina Balabanova, Gunnar Brobert, Samuel Fatoba, Kiliana Suzart-Woischnik, Bernhard Schaefer, Ana Ruigomez

Get full text

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. by Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

Get full text

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe by Luis Alberto García Rodríguez, Montse Soriano-Gabarró, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ana Ruigomez, Leif Friberg, Ron Herings, Karin M A Swart, Tania Schink, Elisabeth Smits, Annemarie Voss, Christine Tarenz, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya

Get full text